Find Scholarly Works

Search concepts
Selected Filters
3 Citations (Scopus)

A 42-Year-Old Woman With a New Diagnosis of Sclerosing Cholangitis

Gossard, A. A. & Lindor, K., Jun 2012, In : Clinical Gastroenterology and Hepatology. 10, 6, p. 593-597 5 p.

Research output: Contribution to journalArticle

Magnetic Resonance Cholangiopancreatography
Sclerosing Cholangitis
Histocytochemistry
Microscopy
Liver
169 Citations (Scopus)

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

Bile Duct Neoplasms
Avitaminosis
Ursodeoxycholic Acid
Sclerosing Cholangitis
Metabolic Bone Diseases
51 Citations (Scopus)

A discrete event simulation model to evaluate operational performance of a colonoscopy suite

Berg, B., Denton, B., Nelson, H., Balasubramanian, H., Rahman, A., Bailey, A. & Lindor, K., May 2010, In : Medical Decision Making. 30, 3, p. 380-387 8 p.

Research output: Contribution to journalArticle

Colonoscopy
Patients' Rooms
Resource Allocation
Cause of Death
Colorectal Neoplasms
11 Citations (Scopus)

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Steatorrhea
Ursodeoxycholic Acid
Cholangiocarcinoma
1 Citation (Scopus)
Sclerosing Cholangitis
Cholangiocarcinoma
Practice Guidelines
Gallbladder Neoplasms
Neoplasms
23 Citations (Scopus)

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Biomarkers
Survival
Liver Transplantation
101 Citations (Scopus)

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K., Apr 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Ursodeoxycholic Acid
Cholangiocarcinoma
Serum
12 Citations (Scopus)

A major step towards effective treatment evaluation in primary biliary cirrhosis

Beuers, U. & Lindor, K., Dec 2011, In : Journal of Hepatology. 55, 6, p. 1178-1180 3 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Biliary Liver Cirrhosis
56 Citations (Scopus)

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis

Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. & Mayo, M. J., Jul 2010, In : Hepatology. 52, 1, p. 349-359 11 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Medical Societies
Patient Selection
Liver Diseases
Research Design
9 Citations (Scopus)

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

Medical Schools
Medical Students
Students
medical student
school
2 Citations (Scopus)

An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., 2014, In : Expert Opinion on Orphan Drugs. 2, 6, p. 545-556 12 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Ursodeoxycholic Acid
Therapeutics
Biliary Liver Cirrhosis
Expert Testimony
17 Citations (Scopus)

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K., May 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Anti-Bacterial Agents
Therapeutics
Bacteremia
Bile Ducts
2 Citations (Scopus)

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

Cholangitis
Antibodies
Autoimmune Hepatitis
Muscles
18 Citations (Scopus)

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Gallbladder Neoplasms
Colorectal Neoplasms
Neoplasms
4 Citations (Scopus)

An update on primary sclerosing cholangitis: From pathogenesis to treatment

Imam, M. H., Talwalkar, J. A. & Lindor, K., Mar 2013, In : Minerva Gastroenterologica e Dietologica. 59, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiography
Causality
Biomedical Research
Liver Diseases
18 Citations (Scopus)

A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis

Adams, L. A., Angulo, P., Petz, J., Keach, J. & Lindor, K., Sep 2010, In : Hepatology International. 4, 3, p. 628-633 6 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Aspartic Acid
Alanine
Therapeutics
Withholding Treatment
309 Citations (Scopus)

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

Cholangitis
Placebos
Ursodeoxycholic Acid
Bilirubin
Alkaline Phosphatase
15 Citations (Scopus)

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Randomized Controlled Trials
Placebos
Safety
17 Citations (Scopus)

A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis

Montali, L., Tanaka, A., Riva, P., Takahashi, H., Cocchi, C., Ueno, Y., Miglioretti, M., Takikawa, H., Vecchio, L., Frigerio, A., Bianchi, I., Jorgensen, R., Lindor, K., Podda, M. & Invernizzi, P., Oct 2010, In : Digestive and Liver Disease. 42, 10, p. 718-723 6 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Quality of Life
Principal Component Analysis
Focus Groups
Self Report
9 Citations (Scopus)

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Immunoglobulin E
Cholangiocarcinoma
Serum
Survival

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Adiposity
Alanine Transaminase
Body Mass Index
Waist Circumference
Fats
192 Citations (Scopus)

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Meta-Analysis
Odds Ratio
Biochemistry
Histology
31 Citations (Scopus)

Autoimmune hepatitis: A review

Gossard, A. A. & Lindor, K., May 2012, In : Journal of Gastroenterology. 47, 5, p. 498-503 6 p.

Research output: Contribution to journalArticle

Autoimmune Hepatitis
Immunosuppressive Agents
Aspartate Aminotransferases
Rare Diseases
Life Expectancy
72 Citations (Scopus)

Autoimmune hepatitis-PBC overlap syndrome: A simplified scoring system may assist in the diagnosis

Neuhauser, M., Bjornsson, E., Treeprasertsuk, S., Enders, F., Silveira, M., Talwalkar, J. & Lindor, K., Feb 2010, In : American Journal of Gastroenterology. 105, 2, p. 345-353 9 p.

Research output: Contribution to journalArticle

Autoimmune Hepatitis
Biliary Liver Cirrhosis
Esophageal and Gastric Varices
Liver
Portal Hypertension

Autoimmune liver diseases

Abbas, G. & Lindor, K., Jan 2011, Autoimmune Disorders: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., p. 1-34 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Autoimmune Diseases
Biliary Liver Cirrhosis
Liver Diseases

Autoimmune Liver Diseases

Talwalkar, J. A. & Lindor, K., Aug 31 2010, Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, p. 250-260 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Autoimmune Diseases
Liver Diseases
55 Citations (Scopus)

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Cell- and Tissue-Based Therapy
B-Lymphocytes
Cholangitis
Antibodies
66 Citations (Scopus)

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

Sinakos, E., Marschall, H. U., Kowdley, K. V., Befeler, A., Keach, J. & Lindor, K., Jul 2010, In : Hepatology. 52, 1, p. 197-203 7 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Bile Acids and Salts
Disease Progression
Lithocholic Acid
91 Citations (Scopus)

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

Tsuda, M., Moritoki, Y., Lian, Z. X., Zhang, W., Yoshida, K., Wakabayashi, K., Yang, G. X., Nakatani, T., Vierling, J., Lindor, K., Gershwin, M. E. & Bowlus, C. L., Feb 2012, In : Hepatology. 55, 2, p. 512-521 10 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
B-Lymphocytes
T-Lymphocytes
Immunoglobulin M
60 Citations (Scopus)

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Bone Diseases
Osteoporosis
Inflammatory Bowel Diseases
Confidence Intervals
1 Citation (Scopus)

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Early Detection of Cancer
Cholangiocarcinoma
Neoplasms
Inflammatory Bowel Diseases
3 Citations (Scopus)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma
165 Citations (Scopus)

Cancer surveillance in patients with primary sclerosing cholangitis

Razumilava, N., Gores, G. J. & Lindor, K., Nov 2011, In : Hepatology. 54, 5, p. 1842-1852 11 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Gallbladder Neoplasms
Neoplasms
Cholangiocarcinoma
Inflammatory Bowel Diseases
21 Citations (Scopus)

Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., 2012, In : Journal of Analytical Oncology. 1, 1, p. 50-55 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Common Hepatic Duct
End Stage Liver Disease
Bile Ducts
10 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Digestive and Liver Disease. 47, 11, p. 924-926 3 p., 2950.

Research output: Contribution to journalArticle

21st Century History
19th Century History
20th Century History
Cholangitis
Biliary Liver Cirrhosis
17 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Terminology
Fibrosis
68 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalArticle

44 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Journal of Hepatology. 63, 5, p. 1285-1287 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Disease Progression
21 Citations (Scopus)

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Patient Preference
Terminology
Fibrosis
11 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Clinical Gastroenterology and Hepatology. 13, 11, p. 1867-1869 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
48 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gastroenterology. 149, 6, p. 1627-1629 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
2 Citations (Scopus)

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases
12 Citations (Scopus)

Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons

Carey, E. J. & Lindor, K., Sep 2012, In : Clinics and Research in Hepatology and Gastroenterology. 36, SUPPL.1

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Chemoprevention
Bile Acids and Salts
Colorectal Neoplasms
Sclerosing Cholangitis
10 Citations (Scopus)

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Fluorescence In Situ Hybridization
Cholangiocarcinoma
Liver Transplantation
Cholangiography
12 Citations (Scopus)

Clinical management of autoimmune biliary diseases

Imam, M. H., Talwalkar, J. A. & Lindor, K., Oct 2013, In : Journal of Autoimmunity. 46, p. 88-96 9 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Autoimmune Hepatitis

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunoglobulin G
Sclerosing Cholangitis
Pathologic Constriction
Steroids
Retroperitoneal Fibrosis
9 Citations (Scopus)

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

Imam, M. H., Thackeray, E. W. & Lindor, K., Feb 2013, In : Colorectal Disease. 15, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Neoplasms
Colonoscopy
Colonic Neoplasms
44 Citations (Scopus)

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K., Jan 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Colonic Neoplasms
Guidelines
Colonoscopy
12 Citations (Scopus)

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jul 14 2016, (Accepted/In press) In : Journal of Clinical Gastroenterology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Tretinoin
Bile Acids and Salts
Alanine Transaminase